These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

510 related items for PubMed ID: 11896439

  • 1. Enhanced antitumor effect and reduced vector dissemination with fiber-modified adenovirus vectors expressing herpes simplex virus thymidine kinase.
    Mizuguchi H, Hayakawa T.
    Cancer Gene Ther; 2002 Mar; 9(3):236-42. PubMed ID: 11896439
    [Abstract] [Full Text] [Related]

  • 2. Transcriptional targeting of RGD fiber-mutant adenovirus vectors can improve the safety of suicide gene therapy for murine melanoma.
    Okada Y, Okada N, Mizuguchi H, Hayakawa T, Nakagawa S, Mayumi T.
    Cancer Gene Ther; 2005 Jul; 12(7):608-16. PubMed ID: 15746944
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of an E1E4-deleted adenovirus expressing the herpes simplex thymidine kinase suicide gene in cancer gene therapy.
    Lanuti M, Gao GP, Force SD, Chang MY, El Kouri C, Amin KM, Hughes JV, Wilson JM, Kaiser LR, Albelda SM.
    Hum Gene Ther; 1999 Feb 10; 10(3):463-75. PubMed ID: 10048398
    [Abstract] [Full Text] [Related]

  • 4. The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity.
    Wildner O, Morris JC.
    Cancer Res; 2000 Aug 01; 60(15):4167-74. PubMed ID: 10945625
    [Abstract] [Full Text] [Related]

  • 5. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D, Vogels R, Havenga M, Avezaat CJ, Bout A, Smitt PS.
    Cancer Res; 2001 Dec 15; 61(24):8743-50. PubMed ID: 11751394
    [Abstract] [Full Text] [Related]

  • 6. Imaging chemically modified adenovirus for targeting tumors expressing integrin alphavbeta3 in living mice with mutant herpes simplex virus type 1 thymidine kinase PET reporter gene.
    Xiong Z, Cheng Z, Zhang X, Patel M, Wu JC, Gambhir SS, Chen X.
    J Nucl Med; 2006 Jan 15; 47(1):130-9. PubMed ID: 16391197
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Adenovirus-mediated suicide gene therapy under the control of Cox-2 promoter for colorectal cancer.
    Wang ZX, Bian HB, Yang JS, De W, Ji XH.
    Cancer Biol Ther; 2009 Aug 15; 8(15):1480-8. PubMed ID: 19571664
    [Abstract] [Full Text] [Related]

  • 11. Fiber-mutant technique can augment gene transduction efficacy and anti-tumor effects against established murine melanoma by cytokine-gene therapy using adenovirus vectors.
    Okada Y, Okada N, Nakagawa S, Mizuguchi H, Kanehira M, Nishino N, Takahashi K, Mizuno N, Hayakawa T, Mayumi T.
    Cancer Lett; 2002 Mar 08; 177(1):57-63. PubMed ID: 11809531
    [Abstract] [Full Text] [Related]

  • 12. Inclusion of the herpes simplex thymidine kinase gene in a replicating adenovirus does not augment antitumor efficacy.
    Lambright ES, Amin K, Wiewrodt R, Force SD, Lanuti M, Propert KJ, Litzky L, Kaiser LR, Albelda SM.
    Gene Ther; 2001 Jun 08; 8(12):946-53. PubMed ID: 11426335
    [Abstract] [Full Text] [Related]

  • 13. miR-122a-regulated expression of a suicide gene prevents hepatotoxicity without altering antitumor effects in suicide gene therapy.
    Suzuki T, Sakurai F, Nakamura S, Kouyama E, Kawabata K, Kondoh M, Yagi K, Mizuguchi H.
    Mol Ther; 2008 Oct 08; 16(10):1719-26. PubMed ID: 18665157
    [Abstract] [Full Text] [Related]

  • 14. Enhanced antitumor effects of a bicistronic adenovirus vector expressing both herpes simplex virus thymidine kinase and monocyte chemoattractant protein-1 against hepatocellular carcinoma.
    Tsuchiyama T, Kaneko S, Nakamoto Y, Sakai Y, Honda M, Mukaida N, Kobayashi K.
    Cancer Gene Ther; 2003 Apr 08; 10(4):260-9. PubMed ID: 12679798
    [Abstract] [Full Text] [Related]

  • 15. Therapy of colon cancer with oncolytic adenovirus is enhanced by the addition of herpes simplex virus-thymidine kinase.
    Wildner O, Blaese RM, Morris JC.
    Cancer Res; 1999 Jan 15; 59(2):410-3. PubMed ID: 9927055
    [Abstract] [Full Text] [Related]

  • 16. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.
    Wiewrodt R, Amin K, Kiefer M, Jovanovic VP, Kapoor V, Force S, Chang M, Lanuti M, Black ME, Kaiser LR, Albelda SM.
    Cancer Gene Ther; 2003 May 15; 10(5):353-64. PubMed ID: 12719705
    [Abstract] [Full Text] [Related]

  • 17. Synergy between the herpes simplex virus tk/ganciclovir prodrug suicide system and the topoisomerase I inhibitor topotecan.
    Wildner O, Blaese RM, Morris JC.
    Hum Gene Ther; 1999 Nov 01; 10(16):2679-87. PubMed ID: 10566896
    [Abstract] [Full Text] [Related]

  • 18. A fiber-modified adenovirus co-expressing HSV-TK and Coli.NTR enhances antitumor activities in breast cancer cells.
    Zhan Y, Yu B, Wang Z, Zhang Y, Zhang HH, Wu H, Feng X, Geng RS, Kong W, Yu XH.
    Int J Clin Exp Pathol; 2014 Nov 01; 7(6):2850-60. PubMed ID: 25031704
    [Abstract] [Full Text] [Related]

  • 19. Use of protamine to augment adenovirus-mediated cancer gene therapy.
    Lanuti M, Kouri CE, Force S, Chang M, Amin K, Xu K, Blair I, Kaiser L, Albelda S.
    Gene Ther; 1999 Sep 01; 6(9):1600-10. PubMed ID: 10490770
    [Abstract] [Full Text] [Related]

  • 20. Generation of fiber-modified adenovirus vectors containing heterologous peptides in both the HI loop and C terminus of the fiber knob.
    Koizumi N, Mizuguchi H, Utoguchi N, Watanabe Y, Hayakawa T.
    J Gene Med; 2003 Apr 01; 5(4):267-76. PubMed ID: 12692861
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.